Physician profile

Omar Z Chohan

Vascular & Interventional Radiology · Williamsville, NY

NPI 1154764918

$54,060.55

in general payments reported to CMS, 2019-2025

27 companies · $774 in 2025

The $774 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).

See the full distribution for Vascular & Interventional Radiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$16,000.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$10,512.50
Travel and Lodging$5,730.24
Food and Beverage$5,542.32

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Okami Medical, INC. $16,196.81 2021-2025 Lobo
Penumbra, INC. $15,959.64 2019-2024 Indigo System, Ruby Coil
Contego Medical, INC $10,089.36 2024-2025 Excipio Sv
Inari Medical, INC. $2,889.77 2020-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Argon Medical Devices, INC. $1,683.20 2023 Cleaner, Cleaner
Ekos Corporation $1,333.57 2019
Abbott Laboratories $736.01 2022-2024 Mitraclip, Jeti Peripheral Catheter
Sirtex Medical INC $676.23 2019-2025 Lava Les (Liquid Embolic System), Sir-Spheres Microspheres
Medtronic, INC. $666.86 2021-2024 Hawkone, Ellipsys Vascular Access System, In.Pact Admiral
Trisalus Life Sciences, INC. $617.41 2023-2025 Trinav Infusion System
Boston Scientific Corporation $489.69 2019-2024 Ekosonic, Embold Fibered
W. L. Gore & Associates, INC. $471.93 2021-2025 Gore Viabahn Vbx Balloon Expandable Endo, Gore Viatorr Tips Endoprosthesis With Controlled Expansion, Gore Viabahn Endoprosthesis With Heparin
Bard Peripheral Vascular, INC. $355.01 2019-2024 Venovo, Set Aspirex S 10f 110cm, Denali Vena Cava Filter
Imperative Care, INC $299.20 2025 Symphony Catheter
Edwards Lifesciences Corporation $278.21 2020-2021
Show all 27 companies
CompanyGeneral paymentsYearsTop products
Shockwave Medical, INC $275.00 2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Inceptus Medical, LLC $263.14 2023 Lobo
Terumo Medical Corporation $189.45 2019-2025 Angio-Seal, Azur Cx Detachable
Cook Medical LLC $179.12 2019-2021
Angiodynamics, INC. $109.12 2020-2023 Auryon Laser System 100-120 Vac
Cardiovascular Systems INC. $95.55 2020-2022
Philips North America LLC $80.48 2019-2024 (P84) Igt Devices Systems
Balt USA, LLC $41.62 2023 Prestige Coil System
Stryker Corporation $38.22 2025 Artix Mt
Shape Memory Medical INC. $18.45 2024 Impede Embolization Plug
E.R. Squibb & Sons, L.L.C. $13.95 2019
Medtronic Vascular, INC. $13.55 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Omar Z Chohan

$54,060.55

in general payments reported 2019-2025

Years
2019-2025
Top company
Okami Medical, INC.
Context
The $774 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).

https://glasscript.com/doctor/1164979/omar-z-chohan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.